🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Entrustpermal Management LLC 13F Filings, Portfolio & Analysis

CIK: 0001438129
New York 900 Third Avenue
Zip Code: 10022
Latest Portfolio Value
$239.5 M
+2.99%
Total Holdings
48
2
Latest Report Date
Q3 2017
Top 10 Concentration
61.96%

Entrustpermal Management LLC — Portfolio Overview & Company Profile

Entrustpermal Management LLC (CIK: 0001438129) is a financial institution headquartered at 900 Third Avenue, , New York, New York 10022. The firm regularly files Form 13F with the U.S. Securities and Exchange Commission (SEC), disclosing its equity holdings and investment positions.

As of the latest reporting period (2017-09-30), the institution manages a portfolio valued at $239.5 M, comprising 48 distinct securities. Over its filing history, it has submitted 18 Form 13F reports.

To view the institution’s full SEC filing history:
🔗 View All SEC Filings

Q3 2017 — Top-10 concentration: 62.0%. Quarterly turnover: 13.8%. ▲ 4 new, +16 added, −8 reduced, ×3 exited.

Portfolio Summary (Q3 2017)

Top Buys

Q3 2017
1. Kite Pharma
+$3.72 M
2. Akorn
+$3.69 M
3. Nxstage Medical
+$3.67 M
5. Tribune Media Co
+$3.54 M

Top Sells

Q3 2017
1. Morgan Stanley China A Share
−$14.82 M
2. Mobileye Global INC Class A
−$3.28 M
3. Vca INC Com
−$3.13 M
−$1.67 M

Asset Allocation

Stocks/ETFs
+0.59%
$205.76 M 85.91%
Options
$0 0.00%
Debt
$0 0.00%
Other
+20.48%
$33.74 M 14.09%

Sector Allocation (Stocks)

Top Stock & ETF Holdings (Q3 2017)

Name Shares Market Value Weight Change Activity
2.36 M $43.36 M 18.10%
1.19 M $18.57 M 7.75% ▼ 107,100 Reduce -8.3%
337,500 $14.62 M 6.10% ▼ 800 Reduce -0.2%
115,487 $14.04 M 5.86% ▼ 23,600 Reduce -17.0%
468,200 $10.99 M 4.59% ▲ 155,800 Add 49.9%
130,800 $7.42 M 3.10%
134,600 $7.36 M 3.07% ▲ 1,200 Add 0.9%
Kite Pharma
N/A
20,700 $3.72 M 1.55% ▲ 20,700 New Buy
Alere
N/A
72,800 $3.71 M 1.55% ▲ 4,000 Add 5.8%
Akorn
N/A
111,200 $3.69 M 1.54% ▲ 111,200 New Buy

Historical Portfolio Charts